leisure time -WSS

leisure time

author：focus 2025-10-01 17:20:30 - browse：65334

A person wears five fitness tracking watches on their wrist — first opinion coverage from STAT — Bebeto Matthews/AP

Turn on your TV or open a web browser this January, and you’ll be bombarded with ads for fitness trackers, smart scales, health apps, and other digital innovations promising to streamline your journey to a happier and healthier you. It’s the time of year when we’re most susceptible to such messaging: Surveys show that at least one-third of our New Year’s resolutions focus on exercising, losing weight, or eating better.

That’s great news for the $45 billion fitness tracking industry, which spends vast sums on advertising designed to convince us that data is the key to better living. The marketing campaigns work: Each January, fitness app downloads spike 36% higher than usual. We’ve also seen the rise of over 400 personalized nutrition companies, while over 12 million people have sequenced their DNA through 23andMe.

Only one problem: The data isn’t working. At least 1.4 million Americans are diagnosed with diabetes each year. Obesity rates soared from 31% to 42% over the past decade. Life expectancy is declining. We were told data would put us in control, but we’re actually less healthy than ever.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Amid AI frenzy, a top HHS official's quest to create safeguards

focus

WSS

HHS secretary Becerra pressed on Change HealthCare cyberattack

Stigma and the return of syphilis

David Sabatini, ex

Heat waves linked to early deliveries, preterm births in new study

Amid AI frenzy, a top HHS official's quest to create safeguards

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

entertainment

leisure time

focus

In age of alternative facts, a scholarly course on calling out crap

Readout Newsletter: CAR

Hepatitis C has a cure — but many Americans still lack access to it

Average age of first period drops to 11.9 years, study shows

Virginia high school admissions case could be legal follow

EPA limits use of carcinogenic gas for sterilizing medical devices

Medical records are filled with copy

Ebola: Gilead Sciences antiviral shows promise as new treatment

Psychedelics group wrestles with new pharma identity

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

hotspot

First U.S. drug developed to treat liver disease MASH is approved

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

John Green on his newest strategy for fighting tuberculosis

First U.S. drug developed to treat liver disease MASH is approved

Medicare coverage of Wegovy, once blocked, now looks possible

Steward Health Care Massachusetts hospitals face fiscal disaster

Wikipedia

focus

explore

leisure time